Literature DB >> 11818342

Danish GPs' perception of disease risk and benefit of prevention.

Jørgen Nexøe1, Dorte Gyrd-Hansen, Jakob Kragstrup, Ivar Sønbø Kristiansen, Jesper Bo Nielsen.   

Abstract

BACKGROUND: Uncertainty and risk are central issues in relation to health and health care services. Healthy individuals do not necessarily fall ill, despite the presence of risk factors. It has been documented that doctors, health service administrators and patients are more inclined to choose interventions against risk factors when information about the effects is presented in terms of relative risk reductions rather than absolute risk reductions.
OBJECTIVES: The objective of the study was to gain better insight into how GPs perceive risk of disease, and how this perception is influenced by the way the risk is presented, e.g. whether changes in risk are presented in absolute or relative terms.
METHODS: Questionnaires with clinical episodes were sent to 1500 Danish GPs. The GPs were randomized into four groups of 375, who all received the same case story with information about risk reduction achieved through medical treatment phrased in terms of either relative risk reduction, absolute risk reduction, number needed to treat or all of the aforementioned terms of risk reduction. The GPs were asked whether they would recommend medical treatment as primary prevention, knowing the case story and expected risk reduction.
RESULTS: The GPs' attitude towards recommending medical treatment was dependent on the phrasing of risk reductions. Seventy-two per cent of doctors who received all information on risk reductions would definitely or probably recommend medication, while 91% would recommend medication if information only about relative risk reduction was given, and 63% would recommend medication if information was given in terms of absolute risk reduction or number needed to treat.
CONCLUSION: In order to advise patients in a rational way, in addition to knowledge of the patients' preferences, doctors need to take into account all available measures of risk reductions.

Entities:  

Mesh:

Year:  2002        PMID: 11818342     DOI: 10.1093/fampra/19.1.3

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  13 in total

Review 1.  Communicating risks at the population level: application of population impact numbers.

Authors:  Richard F Heller; Iain Buchan; Richard Edwards; Georgios Lyratzopoulos; Patrick McElduff; Selwyn St Leger
Journal:  BMJ       Date:  2003-11-15

2.  A proposal for an additional clinical trial outcome measure assessing preventive effect as delay of events.

Authors:  Per Lytsy; Lars Berglund; Johan Sundström
Journal:  Eur J Epidemiol       Date:  2012-12-07       Impact factor: 8.082

3.  A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol.

Authors:  Pablo Alonso-Coello; Alonso Carrasco-Labra; Romina Brignardello-Petersen; Ignacio Neumann; Elie A Akl; Xin Sun; Bradley C Johnston; Matthias Briel; Jason W Busse; Demián Glujovsky; Carlos E Granados; Alfonso Iorio; Affan Irfan; Laura Martínez García; Laura M García; Reem A Mustafa; Anggie Ramirez-Morera; Iván Solà; Kari A O Tikkinen; Shanil Ebrahim; Per O Vandvik; Yuqing Zhang; Anna Selva; Andrea J Sanabria; Oscar E Zazueta; Robin W M Vernooij; Holger J Schünemann; Gordon H Guyatt
Journal:  Syst Rev       Date:  2013-12-13

4.  Perceptions of health risks of cigarette smoking: A new measure reveals widespread misunderstanding.

Authors:  Jon A Krosnick; Neil Malhotra; Cecilia Hyunjung Mo; Eduardo F Bruera; LinChiat Chang; Josh Pasek; Randall K Thomas
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

Review 5.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

6.  Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility.

Authors:  Marianna Fontana; Perviz Asaria; Michela Moraldo; Judith Finegold; Khalil Hassanally; Charlotte H Manisty; Darrel P Francis
Journal:  Circulation       Date:  2014-04-17       Impact factor: 29.690

7.  Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice.

Authors:  Charlotte Gry Harmsen; Dorte Ejg Jarbøl; Jørgen Nexøe; Henrik Støvring; Dorte Gyrd-Hansen; Jesper Bo Nielsen; Adrian Edwards; Ivar Sønbø Kristiansen
Journal:  BMC Health Serv Res       Date:  2013-02-25       Impact factor: 2.655

8.  Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?

Authors:  Henrik Stovring; Dorte Gyrd-Hansen; Ivar S Kristiansen; Jorgen Nexoe; Jesper B Nielsen
Journal:  BMC Med Inform Decis Mak       Date:  2008-06-19       Impact factor: 2.796

9.  GPs' Perceptions of Cardiovascular Risk and Views on Patient Compliance: A Qualitative Interview Study.

Authors:  Benedicte Lind Barfoed; Dorte Ejg Jarbøl; Maja Skov Paulsen; Palle Mark Christensen; Peder Andreas Halvorsen; Jesper Bo Nielsen; Jens Søndergaard
Journal:  Int J Family Med       Date:  2015-10-08

10.  Determinants for acceptance of preventive treatment against heart disease - a web-based population survey.

Authors:  Nielsen Jesper Bo; Jarbøl Dorte Ejg; Gyrd-Hansen Dorte; Barfoed Benedicte Marie Lind; Larsen Pia Veldt
Journal:  BMC Public Health       Date:  2014-08-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.